Stay at the forefront of breast cancer treatment advancements by joining this essential live discussion on the latest data from Chicago 2024. Led by top experts in breast cancer oncology, this brief and engaging 45-minute session will cover:
- HER2-Directed ADCs: New findings in hormone receptor-positive HER2-low metastatic breast cancer, including chemotherapy-naive patient data.
- TROP2 Targeting ADCs: In-depth discussion on this emerging treatment option.
- Post-Progression Treatment: Strategies following progression on first-line CDK 4/6 inhibitors plus endocrine therapy.
Bring your questions to share with our esteemed faculty panel.
- - - - -
Moderator: Fabrice André, MD, PhD
Faculty: Aditya Bardia, MD, MPH, FASCO
Faculty: Erika Hamilton, MD
- - - - -
Earn free 0.75 CPD. Access for credit will be shared at the end of this live event.
Click the link to view the Accreditation and Disclosure details before participating: www.medscape.o...
Supported by an independent educational grant from AstraZeneca.
Негізгі бет Ask the Expert: Understanding the Latest Advances in Breast Cancer
No video
Пікірлер